InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

EXELIXIS, INC.

EXEL Clue Score84
United States Fiscal year ends January CIK 0000939767
$59.86 +1.42% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $59.86 +176.23% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue191.5Operating income−28.1Net income−70.2Fiscal year 2017Revenue452.5 +136.3%Operating income165.9Net income154.2EPS, diluted0.49Fiscal year 2018Revenue853.8 +88.7%Operating income438.9Net income690.1 +347.4%EPS, diluted2.21 +351.0%Fiscal year 2020Revenue967.8 +13.3%Operating income369.5Net income321.0 −53.5%EPS, diluted1.02 −53.8%Fiscal year 2021Revenue987.5 +2.0%Operating income110.1Net income111.8 −65.2%EPS, diluted0.35 −65.7%Fiscal year 2021Revenue1,435.0 +45.3%Operating income286.7Net income231.1 +106.7%EPS, diluted0.72 +105.7%Fiscal year 2022Revenue1,611.1 +12.3%Operating income201.5Net income182.3 −21.1%EPS, diluted0.56 −22.2%Fiscal year 2023Revenue1,830.2 +13.6%Operating income170.9Net income207.8 +14.0%EPS, diluted0.65 +16.1%Fiscal year 2025Revenue2,168.7 +18.5%Operating income604.6Net income521.3 +150.9%EPS, diluted1.76 +170.8%Fiscal year 2026Revenue2,320.1 +7.0%Operating income872.2Net income782.6 +50.1%EPS, diluted2.78 +58.0%
FY2016FY2017FY2018FY2020FY2021FY2021FY2022FY2023FY2025FY2026
Revenue 191.5 452.5 853.8 967.8 987.5 1,435.0 1,611.1 1,830.2 2,168.7 2,320.1
Growth +136.3% +88.7% +13.3% +2.0% +45.3% +12.3% +13.6% +18.5% +7.0%
Operating income −28.1 165.9 438.9 369.5 110.1 286.7 201.5 170.9 604.6 872.2
Net income −70.2 154.2 690.1 321.0 111.8 231.1 182.3 207.8 521.3 782.6
Growth +347.4% −53.5% −65.2% +106.7% −21.1% +14.0% +150.9% +50.1%
EPS, diluted n/a 0.49 2.21 1.02 0.35 0.72 0.56 0.65 1.76 2.78
Growth +351.0% −53.8% −65.7% +105.7% −22.2% +16.1% +170.8% +58.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−14.7%Net margin−36.7%Free cash flow margin106.9%Fiscal year 2017Operating margin36.7%Net margin34.1%Free cash flow margin31.9%Fiscal year 2018Operating margin51.4%Net margin80.8%Free cash flow margin44.8%Fiscal year 2020Operating margin38.2%Net margin33.2%Free cash flow margin53.1%Fiscal year 2021Operating margin11.1%Net margin11.3%Free cash flow margin18.1%Fiscal year 2021Operating margin20.0%Net margin16.1%Free cash flow margin24.2%Fiscal year 2022Operating margin12.5%Net margin11.3%Free cash flow margin20.8%Fiscal year 2023Operating margin9.3%Net margin11.4%Free cash flow margin16.0%Fiscal year 2025Operating margin27.9%Net margin24.0%Free cash flow margin31.0%Fiscal year 2026Operating margin37.6%Net margin33.7%Free cash flow margin37.7%
FY2016FY2017FY2018FY2020FY2021FY2021FY2022FY2023FY2025FY2026
Operating margin −14.7% 36.7% 51.4% 38.2% 11.1% 20.0% 12.5% 9.3% 27.9% 37.6%
Net margin −36.7% 34.1% 80.8% 33.2% 11.3% 16.1% 11.3% 11.4% 24.0% 33.7%
Free cash flow margin 106.9% 31.9% 44.8% 53.1% 18.1% 24.2% 20.8% 16.0% 31.0% 37.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow206.3Capital expenditure−1.7Free cash flow204.6Fiscal year 2017Operating cash flow165.6Capital expenditure−21.1Free cash flow144.5 −29.4%Fiscal year 2018Operating cash flow415.7Capital expenditure−33.3Free cash flow382.4 +164.7%Fiscal year 2020Operating cash flow527.0Capital expenditure−12.8Free cash flow514.1 +34.4%Fiscal year 2021Operating cash flow209.0Capital expenditure−30.3Free cash flow178.6 −65.3%Fiscal year 2021Operating cash flow400.8Capital expenditure−54.2Free cash flow346.6 +94.0%Buybacks0.0Fiscal year 2022Operating cash flow362.6Capital expenditure−27.7Free cash flow334.9 −3.4%Buybacks0.0Fiscal year 2023Operating cash flow333.3Capital expenditure−40.5Free cash flow292.9 −12.6%Buybacks−550.4Fiscal year 2025Operating cash flow700.0Capital expenditure−28.4Free cash flow671.5 +129.3%Buybacks−652.0Fiscal year 2026Operating cash flow884.3Capital expenditure−8.4Free cash flow875.8 +30.4%Buybacks−947.5
FY2016FY2017FY2018FY2020FY2021FY2021FY2022FY2023FY2025FY2026
Operating cash flow 206.3 165.6 415.7 527.0 209.0 400.8 362.6 333.3 700.0 884.3
Capital expenditure −1.7 −21.1 −33.3 −12.8 −30.3 −54.2 −27.7 −40.5 −28.4 −8.4
Free cash flow 204.6 144.5 382.4 514.1 178.6 346.6 334.9 292.9 671.5 875.8
Growth −29.4% +164.7% +34.4% −65.3% +94.0% −3.4% −12.6% +129.3% +30.4%
Buybacks n/a n/a n/a n/a n/a 0.0 0.0 −550.4 −652.0 −947.5

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash151.7Total debt189.1Net cash (debt)−37.4Shareholders’ equity89.3Debt to equity2.12Fiscal year 2017Cash183.2Total debt0.0Net cash (debt)183.2Shareholders’ equity285.0Debt to equity0.00Fiscal year 2018Cash314.8Shareholders’ equity1,287.5Fiscal year 2020Cash266.5Shareholders’ equity1,686.0Fiscal year 2021Cash319.2Shareholders’ equity1,879.1Fiscal year 2021Cash647.2Shareholders’ equity2,210.6Fiscal year 2022Cash501.2Shareholders’ equity2,488.4Fiscal year 2023Cash263.0Shareholders’ equity2,263.9Fiscal year 2025Cash217.4Shareholders’ equity2,244.2Fiscal year 2026Cash482.5Shareholders’ equity2,161.3
FY2016FY2017FY2018FY2020FY2021FY2021FY2022FY2023FY2025FY2026
Cash 151.7 183.2 314.8 266.5 319.2 647.2 501.2 263.0 217.4 482.5
Total debt 189.1 0.0 n/a n/a n/a n/a n/a n/a n/a n/a
Net cash (debt) −37.4 183.2 n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders’ equity 89.3 285.0 1,287.5 1,686.0 1,879.1 2,210.6 2,488.4 2,263.9 2,244.2 2,161.3
Debt to equity 2.12 0.00 n/a n/a n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending January, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 30 Dec 2016 FY2016 31 Dec 2016 FY2017 29 Dec 2017 FY2018 28 Dec 2018 FY2020 3 Jan 2020 FY2021 1 Jan 2021 FY2021 31 Dec 2021 FY2022 30 Dec 2022 FY2023 29 Dec 2023 FY2025 3 Jan 2025 FY2026 2 Jan 2026
Operations
210.4 206.3 165.6 415.7 527.0 209.0 400.8 362.6 333.3 700.0 884.3
Growth −2.0% −19.7% +151.0% +26.8% −60.3% +91.8% −9.5% −8.1% +110.0% +26.3%
1.0 1.0 1.2 4.9 8.3 9.1 13.6 20.9 25.7 28.8 29.1
Investment
−1.7 −1.7 −21.1 −33.3 −12.8 −30.3 −54.2 −27.7 −40.5 −28.4 −8.4
calc 208.7 204.6 144.5 382.4 514.1 178.6 346.6 334.9 292.9 671.5 875.8
Growth −2.0% −29.4% +164.7% +34.4% −65.3% +94.0% −3.4% −12.6% +129.3% +30.4%
calc 0.83 n/a 0.46 1.22 1.63 0.56 1.08 1.03 0.91 2.27 3.11
−214.5 −216.0 36.8 −297.9 −587.2 −131.2 −42.9 −524.4 −27.0 −116.8 350.4
Financing
15.7 19.8 −169.9 9.7 12.6 −25.1 −14.8 0.6 −546.1 −628.8 −969.6
n/a n/a n/a n/a n/a n/a 0.0 0.0 −550.4 −652.0 −947.5

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.